Non-parametric estimation of net survival under dependence between death causes
Oskar Laverny, Nathalie Grafféo, Roch Giorgi
TL;DR
This paper tackles relative survival analysis when the standard independence between excess deaths $E$ and competing mortality $P$ is questionable. It introduces a generalized non-parametric Pohar Perme estimator under a copula-based dependence $(\mathcal{H}_{\mathcal{C}})$, derives counting-process–based asymptotics, and provides variance estimation and a log-rank-type test for group differences. Through simulations, it demonstrates that misspecifying the dependence structure can bias excess survival estimates and corrupt inference, while a correctly specified copula yields reliable results; a colorectal cancer registry application illustrates the substantial impact of the dependence assumption on both estimates and uncertainty. The work highlights a practical pathway to assess and account for dependence in relative survival, while noting that plug-in estimators and copula specification remain key areas for further theoretical and empirical refinement.
Abstract
Relative survival methodology deals with a competing risks survival model where the cause of death is unknown. This lack of information occurs regularly in population-based cancer studies. Non-parametric estimation of the net survival is possible through the Pohar Perme estimator. Derived similarly to Kaplan-Meier, it nevertheless relies on an untestable independence assumption. We propose here to relax this assumption and provide a generalized non-parametric estimator that works for other dependence structures, by leveraging the underlying stochastic processes and martingales. We formally derive asymptotics of this estimator, providing variance estimation and log-rank-type tests. Our approach provides a new perspective on the Pohar Perme estimator and the acceptability of the underlying independence assumption. We highlight the impact of this dependence structure assumption on simulation studies, and illustrate them through an application on registry data relative to colorectal cancer, before discussing potential extensions of our methodology.
